The Official page of the Herbert Irving Comprehensive Cancer Center (HICCC) of NewYork-Pres
(44)
The Herbert Irving Comprehensive Cancer Center (HICCC) is the home for cancer research and patient care at Columbia University and NewYork-Presbyterian/Columbia University Irving Medical Center. Our cancer center researchers and physicians are dedicated to understanding the complex biology behind cancer, from before it begins to its evolution and spread. We apply that knowledge to the discovery an
d design of innovative cancer therapies and prevention strategies that reduce cancer's incidence and progression and improve the quality of life for all those affected - in our region and throughout the world. The HICCC is one of only 51 National Cancer Institute (NCI)-designated comprehensive cancer centers in the United States, a designation that we have maintained since 1979. The HICCC has more than 200 members across six schools at Columbia University with more than $20 million in National Cancer Institute funding and nearly $100 million in cancer grants. Partnering with the top hospital and leading academic center in New York City, NewYork-Presbyterian Hospital and Columbia University, the HICCC fosters a community of scientific excellence and outstanding patient care.
Sasha's journey through cancer treatment, recovery, and survivorship offers a powerful reminder: it takes a village. Today, National Cancer Survivors Day, we honor all those facing cancer, remember those we’ve lost, and champion survivors and their care teams.
https://youtu.be/dsmPvuXHD-Y
Sasha's journey through cancer treatment, recovery, and survivorship offers a powerful reminder: it takes a village.
Today, National Cancer Survivors Day, we honor all those facing cancer, remember those we’ve lost, and champion survivors and their care teams.
https://youtu.be/dsmPvuXHD-Y
AACR’s 2024 annual meeting starts tomorrow! Stay up to date here on exciting research being presented by HICCC physicians and scientists and tag us in your meeting highlights to be featured. American Association for Cancer Research (AACR)
https://www.cancer.columbia.edu/news/roundup-hiccc-aacr-2024
Facing a cancer diagnosis can feel overwhelming for patients. “One major stressor is the uncertainty about the course their cancer will take," says Columbia University Irving Medical Center psychologist Jon Levenson, MD. Read more in the article from TIME.
Support groups and meeting with a therapist can help.
At just 31, Rachel Secrest was shocked to learn she had colorectal cancer. But thanks to the care of Beatrice Dionigi, MD and Alfred Neugut, MD, the professional dancer is cancer-free and can return to the stage.
At 31, Rachel Secrest was shocked to learn that a painful mass in her colon was cancer. But thanks to the care of experts at NewYork-Presbyterian, the contemporary dancer is now cancer free — and set to return to the stage.
Join us in welcoming Eun-Ju Lee, MD! As a Doris Duke Clinical Research Fellow and recipient of an NIH NIDDK student research training grant, Dr. Lee brings expertise in idiopathic thrombocytopenic purpura (ITP).
Why is colorectal cancer on the rise in people younger than 55? Read more as Dr. Benjamin Lebwohl and Dr. Beatrice Dionigi explain the trend and stress the importance of early screening and awareness.
A gastroenterologist explains the rise of colorectal cancer diagnoses in adults younger than 55, and when people should see a specialist.
Meet Tyler Nichols, a dedicated Columbia Public Health student committed to health equity and policy. Read more on how his work with the CHURCH Trial drives diversity dialogues and empowers underrepresented voices in healthcare.
MPH student Tyler Nichols writes about his public health education in and out of the classroom.
Did you know colorectal cancer is the second leading cause of cancer death in the US? Fortunately, it's highly preventable with proper screening, and Dr. Daniel Freedberg shares colonoscopy prep tips to help you prepare for it. https://healthmatters.nyp.org/colonoscopy-prep-tips/
Starfysh- a computational tool developed by Elham Azizi, PhD- revolutionizes the study of gene expression within tissues. Read more on the study published in Nature Biotechnology, which will provide insights into disease dynamics, especially in cancer research.
https://cancerdynamics.columbia.edu/news/iicd-researchers-introduce-starfysh-breakthrough-tool-transforming-spatial-gene-expression
We are excited to introduce our "Staff Shout Outs", a new series that will spotlight our amazing HICCC staff members! Our second shout out goes to Alexis Pissey Keo, [Diversity, Equity and Inclusion Clinical Research Manager]. Says Edward Bentylewski, "Alexis has been a key member in advancing our DEI efforts and doing stellar work in our diversity equity and inclusion clinical trial training program. She approaches each challenge with enthusiasm and contributes to many of the amazing projects in the CPDM."
Congratulations to Carla Concepcion-Crisol, PhD, for being selected as the recipient of the Alice Bohmfalk Charitable Trust Award. This award supports early career scientists with their initial scientific work at Columbia University’s College of Physicians and Surgeons.
Meet Rev. Dr. Gail Badger, a community health worker whose own colorectal cancer diagnosis led her to activism. She’s a passionate and positive force in helping church members and others take the step to get potentially lifesaving screening!
Our DEI office hosted a fantastic event! The LGBTQIA+ Affinity in Academica featured panelists Emily Mace, PhD, and Santiago Correa, PhD, discussing inclusivity in biomedical research and their experiences navigating academia as LGBTQIA+ individuals.
Congratulations to the recipients of the 2023 Trainee Associate Membership (TAM) pilot grants, travel awards, and paper(s) of the year! These are internal mentored research awards given to support graduate students, medical students, and postgraduate researchers in their cancer research endeavors.
Congratulations to our Trainee Associate Membership program awardees, including our predoctoral and postdoctoral pilot awards, travel awards and papers of the year!
Dr. Tomoaki Kato's motto is simple yet powerful: Don’t say ‘no’ just because it’s never been done before." This message of resillience and focus has served him well, from performing the first ever six-organ ex-vivo surgery, to surviving his own intense battle with COVID-19 in 2020. Read more about his inspiring story!
https://www.nyp.org/advances/physicianstories/tomoaki-kato
Congrats to Columbia Public Health's Gary Miller, PhD for leading a SAMBAI team for , addressing cancer disparities by using exposomics to understand influencing environmental, genetic, and social factors.
Professor Gary Miller is leading one arm of a research project to understand cancer disparities in people of African descent.
We are excited to introduce our "Staff Shout Outs", a new series that will spotlight our amazing HICCC staff members! Our first shout out goes to Holly Swaminathan, [Assistant Director of Research, Finance and Reporting]. Says Moshe Kelsen, CFO, "Holly is a true team player and an exceptional leader within our administrative team. The way she interacts, collaborates and treats all with equal respect fully embodies the culture for which we strive for in the HICCC. For this reason and many more she is an obvious choice for our inaugural HICCC Staff Shout-Out."
Congratulations to Ana Navas-Acien, MD, PhD, MPH, who has been appointed the next Leon Hess Professor & Chair of Environmental Health Sciences at Columbia Public Health. A global scholar, environmental justice champion, and mentor, read more about how she is set to lead environmental health research and train future leaders.
Navas-Acien is an internationally renowned scholar and instructor and champion of environmental justice.
Ferroptosis, a type of cell death discovered by Columbia Professor Brent Stockwell, may be driven by a rare fat molecule, new research finds. These lipids may be the key to inducing cell death or stopping it, which could improve treatments for certain cancers or neurodegenerative diseases.
The discovery that a lipid helps induce cell death could improve treatments for certain cancers and neurodegenerative diseases.
Why is colon cancer on the rise in people under 50? Read more about how Joel Gabre, MD, and collaborators are using organoids- complex cell structures- to understand possible drivers of early onset colon cancer.
A team of Columbia scientists is examining patient samples and experimenting with organoids to understand why colon cancer is on the rise in people under 50.
Dr. Wakenda Tyler, Chief of Orthopedic Oncology at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, is breaking barriers in orthopedics, tackling diversity gaps that are typically overlooked in this specialty. She shares how her research is advancing orthopedic oncology, addressing disparities, and ensuring better patient care.
Tackling health disparities in the care of orthopedic cancer patients
Fast-tracking drug approvals - is getting lifesaving treatments into the hands of those that need them worth the risk? In a new Nature Cancer commentary, Susan Bates, MD and others assert that the benefits accelerated programs outweigh any potential issues.
Experts reviewed withdrawals across fast-track drug approval programs, finding that overall, these programs contribute positively to drug development with little safety concerns.
We are celebrating the impactful women of Columbia University Irving Medical Center on ! From clinicians to educators, scientists to alumni, learn more about these remarkable women who have left lasting imprints throughout history.
Many women connected to CUIMC have made deep and lasting imprints over the years. Meet some of the remarkable clinicians, educators, scientists, and alumni from throughout history.
Columbia BME professor Ke Cheng and his team are pioneering research in direct lung targeting, reducing side effects and enhancing the immune response. Explore the potential of inhaled nanobubbles for advancing treatment possibilities.
Columbia Biomedical Engineer Ke Cheng has developed a technique that uses inhalation of exosomes, or nanobubbles, to directly deliver IL-12 mRNA to the lungs of mice.
Our Columbia investigators’ recent research highlights the link between alcohol-related liver disease (ALD) and cancer. Learn more about how this emphasizes the importance of personalized cancer risk assessments for people with ALD.
An international research team that includes Columbia faculty in gastroenterology and hepatology evaluates the long-term risk of hepatocellular carcinoma in persons with ALD to determine if surveillance is warranted.
Lewis Silverman, MD, has been appointed director of the Hope and Heroes Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation. Read more on how Dr. Silverman aims to advance patient outcomes and contribute to the Department of Pediatrics at CUIMC. Welcome, Dr. Silverman!
Lewis Silverman, MD will join the Department of Pediatrics as director of the Hope and Heroes Division of Pediatric Hematology, Oncology and Transplantation.
Columbia Thyroid Center's Interventional Endocrinology Program, led by Dr. Jennifer Kuo, is transforming thyroid care with Radiofrequency Ablation (RFA) and other cutting-edge techniques. Read more about the latest advancements.
We sat down with Dr. Jennifer Kuo, an international leader in thermal ablation for thyroid nodules, to get an update on the latest techniques and treatments.
We're kicking off with Dr. Karen Antman, the first female director of the ! Dr. Antman, now dean of Boston University Medicine, led the cancer center through a period of explosive growth and exciting cancer breakthroughs. Read more:
Under her directorship, Dr. Karen Antman led the expansion of the Cancer Center's clinical arm, infrastructure and multi-disciplinary care.
We are rounding out Cancer Prevention Month with a spotlight on our amazing Community Outreach and Engagement team. Read more about how they're turning research into action, partnering with communities to tackle critical needs.
The HICCC's Community Outreach and Engagement Office works side by side with the communities they serve, putting research into action through programs that address critical needs.
1130 St. Nicholas Avenue, Room 508
New York, NY
10032
Be the first to know and let us send you an email when Herbert Irving Comprehensive Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Herbert Irving Comprehensive Cancer Center:
Sasha's journey through cancer treatment, recovery, and survivorship offers a powerful reminder: it takes a village. Today, National Cancer Survivors Day, we honor all those facing cancer, remember those we’ve lost, and champion survivors and their care teams. #NCSD2024 https://youtu.be/dsmPvuXHD-Y
Meet Rev. Dr. Gail Badger, a community health worker whose own colorectal cancer diagnosis led her to activism. She’s a passionate and positive force in helping church members and others take the step to get potentially lifesaving screening!
Five new initiatives at the HICCC are addressing key questions in cancer research at every stage of the disease. Together, they're allowing us to see the big picture and work together to stop cancer in its tracks. #HICCCAR23 https://pubs.cancer.columbia.edu/the-big-picture
The HICCC 2023 Annual Report is here! It's been a fantastic year for cancer research and care at Columbia, and we're excited to share the all the latest advancements with you. Follow along with us using #HICCCAR23
🚲 Gear up for Velocity: Columbia’s Ride to End Cancer! Our promo video showcases how our annual cycling event (@velocity_ride) supports cancer research and patient care at Columbia’s Herbert Irving Comprehensive Cancer Center. 🚲 Full Video: https://app.frame.io/presentations/9dafb0e2-7970-41e1-8f94-bb24743ea53c
HICCC radiation oncologists Zahra Ghiassi-Nejad, MD, PhD, and Eileen Connolly, MD, PhD, share what you need to know about partial vs whole breast radiation to treat #breastcancer. 👇
What's the difference between #adjuvant and #neoadjuvant treatment? HICCC's Breast Oncology Team explains. 👇 #BreastCancerAwarenessMonth2023
This year, join us in making #ClinicalTrialsDay ➡️ Diversity in Clinical Trials Day. #CTD2023
On #AMLWorldAwarenessDay, hear from Dr. Stavroula Kousteni and Dr. Azra Raza about their hopes for the Edward P. Evans MDS Center at Columbia, making groundbreaking discoveries that stop #AML before it starts. #KnowAML Watch more: https://youtu.be/mLmtY_QTw6U
Yesterday, the HICCC's Office of Community Outreach and Engagement met with community partners, including Dr. Ginny Mantello of the Office of the Staten Island Borough President and Dr. Ana Mendez of Richmond University Medical Center, to celebrate the unveiling of their new HPV prevention PSA. The PSA, located at both the Staten Island Ferry terminals, aims to increase HPV vaccination across Staten Island, which currently has the lowest HPV vaccination rates among all NYC boroughs. Learn more about our efforts in cancer prevention across Staten Island: https://www.cancer.columbia.edu/news/raising-awareness-skin-cancer-and-hpv-vaccination-staten-island
This #InternationalWomensDay, the HICCC celebrates all of our doctors, patients, researchers, and staff, who have worked together to advance equitable cancer care for all. #EmbraceEquity #IWD23 #IWD
HICCC chaplain Soren Glassing and psychologist Ian Sadler, PhD, share some words of compassion and support on #NationalCaregiversDay. To all our patient caregivers, we recognize and thank you for all that you do. 💙 #caregivers #caregiversday #patientcare #cancercare
Dr. Kenneth Forde was a pioneering colorectal surgeon and early proponent of colon cancer screening. In addition to his contributions to the field, he is remembered today by friends and colleagues as a champion for diversity in medicine. #blackhistorymonth2023
This World Cancer Day we hope you'll join us in reflecting on what we all can do to help close the care gap and end cancer for all. #WorldCancerDay
Current research has shown that Black women have poorer #breastcancer outcomes, but the reasons for the observed inequities are unclear. Below Dr. Adana Llanos discusses how we must shift our focus to factors beyond race to better understand breast cancer risk and outcomes.
This afternoon the First Lady and Queen Letizia are meeting with our researchers to discuss some of our key initiatives and alignment with President Biden's #CancerMoonshot. Take a look below and click here to stream their remarks at 1:15 PM: https://www.youtube.com/watch?v=shm0rrq2BXo
Fifty years ago, our understanding of cancer, how it works, how to treat it, was nowhere near what our physicians and scientists can do today. Join us on September 15 as we celebrate our 50th Anniversary of NCI designation and look ahead at the many breakthroughs to come in cancer research and care. Register now: https://www.eventbrite.com/e/hiccc-50th-anniversary-symposium-tickets-371436916817
Below, meet Velocity rider Danny Chavarria and hear why he's joining us on October 2 to raise money for life changing cancer research at Columbia. What's your why? Register for Velocity Ride today and share your story: https://www.velocityride.org/index.cfm?fuseaction=register.start&eventID=526
#SarcomaAwarenessMonth Watch below as sarcoma specialists Gary Schwartz, MD, and Matt Ingham, MD, break down what needs to be done to address this complex and rare group of cancers.
A Center For Dental Excellence: Valerie Vente
8510 Bay 16th Street
Acousticon of Flushing Hearing Aid Center
Main Street
Dental Implantology & Aesthetic Dentistry
30th Avenue Ste
Physicians for a National Health Program (PNH
W. 33rd Street
Cosmetic Medical Training for Models
Lafayette Street
